EMEA-001601-PIP01-13

Key facts

Active substance
Misoprostol
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0124/2015
PIP number
EMEA-001601-PIP01-13
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Induction of labour
Route(s) of administration
  • Oral use
  • Sublingual use
  • Vaginal use
Contact for public enquiries
Azanta Danmark A/S
Denmark
Tel. +45 70259545
Fax +45 70259546
E-mail: cm@azanta.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating